Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4349940)

Published in Bioinformation on January 30, 2015

Authors

Andre Barkhordarian1, April D Thames2, Angela M Du3, Allison L Jan3, Melissa Nahcivan3, Mia T Nguyen3, Nateli Sama3, Francesco Chiappelli1

Author Affiliations

1: UCLA School of Dentistry Oral Biology & Medicine ; Evidence-Based Decision Practice-Based Research Network.
2: UCLA David Geffen School of Medicine Psychiatry.
3: UCLA School of Dentistry Oral Biology & Medicine.

Articles cited by this

Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08

The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep (2014) 4.97

Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med (2006) 4.16

Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med (2013) 3.92

Viral encephalitis: familiar infections and emerging pathogens. Lancet (2002) 3.80

Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol (2000) 2.64

Origins of CD4(+) effector and central memory T cells. Nat Immunol (2011) 2.35

Trafficking of immune cells in the central nervous system. J Clin Invest (2010) 2.17

Essentials of Th17 cell commitment and plasticity. Blood (2013) 1.95

Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J Cereb Blood Flow Metab (2005) 1.63

Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue. Crit Rev Immunol (2001) 1.61

Clinical features and pathobiology of Ebolavirus infection. J Autoimmun (2014) 1.56

Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci (2005) 1.54

Characterization of host immune responses in Ebola virus infections. Expert Rev Clin Immunol (2014) 1.52

Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury? Stroke (2003) 1.25

A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog (2013) 1.16

Long term immunologic consequences of experimental stroke and mucosal tolerance. Exp Transl Stroke Med (2009) 1.15

CNS immune responses following experimental stroke. Neurocrit Care (2009) 1.11

Filoviral immune evasion mechanisms. Viruses (2011) 1.10

Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus. J Neuroinflammation (2012) 1.10

HIV is trapped and masked in the cytoplasm of lymph node follicular dendritic cells. Am J Pathol (1997) 1.03

The contextual role of TNFR family members in CD8(+) T-cell control of viral infections. Immunol Rev (2013) 0.97

Poliovirus tropism and attenuation are determined after internal ribosome entry. J Clin Invest (2004) 0.97

Small RNA-mediated regulation of host-pathogen interactions. Virulence (2013) 0.96

Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markers. J Neurotrauma (2007) 0.95

Multipronged CD4(+) T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus. Immunol Rev (2013) 0.93

The role of the microenvironment in tumor immune surveillance. Bioinformation (2011) 0.88

The gateway theory: bridging neural and immune interactions in the CNS. Front Neurosci (2013) 0.86

The gateway theory: how regional neural activation creates a gateway for immune cells via an inflammation amplifier. Biomed J (2014) 0.79

Regulation of immune cell infiltration into the CNS by regional neural inputs explained by the gate theory. Mediators Inflamm (2013) 0.78